首页> 外国专利> Pharmaceutical compositions containing tadalafil and cyclodextrin

Pharmaceutical compositions containing tadalafil and cyclodextrin

机译:包含他达拉非和环糊精的药物组合物

摘要

1. A solid pharmaceutical composition comprising a co-granulate of tadalafil with beta-cyclodextrin in a molar ratio greater than 1: 1 and at least one pharmaceutically acceptable extragranular ekstsipient.2. The composition of claim 1 wherein the extragranular excipient is a disintegrant, preferably croscarmellose natriya.3. A composition according to claim 2, wherein the amount of disintegrant is from 1 to 5 wt.% Of the total weight kompozitsii.4. A composition according to claims 1-3, wherein the starting substance tadalafil Cialis fraction comprises particles having a particle size d (0,9) 40 mikron.5. A composition according to claim 1, wherein the relative amount of the co-granulate tadalafil / beta-cyclodextrin in the composition is from about 30 to about 80 wt.%, Preferably from about 40 to about 60 wt.% Of the total weight kompozitsii.6. The composition of claim 1 wherein the co-granulate contains at least one other intragranular ekstsipient.7. A composition according to claim 6 wherein the intragranular excipient is solyubilizator.8. A composition according to claim 1, wherein the molar ratio between tadalafil and beta-cyclodextrin is less than 1: 8.9. A composition according to claim 8, wherein the molar ratio between tadalafil and beta-cyclodextrin is about 1: 1.25, 1: 1.3, 1: 1.5, 1: 2, 1: 2.5, 1: 3.10. Compressed tablet for oral administration of tadalafil, comprising a dosage amount of the composition according to any one pp.1-9.11. A tablet according to claim 10, comprising from 1 to 50 mg tadalafila.12. A tablet according to claim 10, wherein the dissolution rate of at least about 75 wt.% In about 15 minutes when tested by a paddle stirrer Ph. Eur. in 1000 mL aqueous medium containing 0.35% laurilsul
机译:1.一种固体药物组合物,其包含他达拉非与β-环糊精的摩尔比大于1∶1的共颗粒和至少一种药学上可接受的颗粒外ekssipient。权利要求1的组合物,其中颗粒外赋形剂是崩解剂,优选地是羧甲基纤维素3。 3.根据权利要求2的组合物,其中崩解剂的量为kompozitsii.4总重量的1至5重量%。 4.根据权利要求1-3的组合物,其中起始物质他达拉非Cialis级分包含具有d(0,9)40 mikron.5的粒径的颗粒。 2.根据权利要求1的组合物,其中组合物中他达拉非/β-环糊精的共颗粒的相对量为kompozitsii总重量的约30至约80重量%,优选约40至约60重量%。 .6。权利要求1的组合物,其中所述共颗粒包含至少一种其他颗粒内ekstsipient.7。 7.根据权利要求6的组合物,其中所述颗粒内赋形剂是增溶剂8。 2.根据权利要求1的组合物,其中他达拉非和β-环糊精之间的摩尔比小于1∶8.9。 9.根据权利要求8的组合物,其中他达拉非和β-环糊精之间的摩尔比为约1:1.25、1:1.3、1:1.5、1:2、1:2.5、1:3.10。用于他达拉非口服给药的压制片剂,其包含一定剂量的根据第1-9.11项中任一项的组合物。 11.根据权利要求10的片剂,其包含1至50mg的tadalafila.12。 11.根据权利要求10所述的片剂,其中,当通过桨式搅拌器Ph.Eur。进行测试时,在约15分钟内的溶出率为至少约75重量%。在含有0.35%月桂醇的1000 mL水性介质中

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号